Advertisement

Organisation › Details
Karo Pharma (Group)
Karo Pharma is a Health Care company, which develops and markets products for pharmacies, regular shops and directly to the Health Care community. The share is listed on Nasdaq Stockholm. *
![]() |
Start | 2016-01-01 renamed date ca |
Predecessor | Karo Bio (Group) | |
![]() |
Region | Stockholm |
Country | Sweden | |
Street | 7 Nybrokajen | |
City | Stockholm | |
Tel | +46-10-3302310 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for �About Section�: Oasmia Pharmaceutical AB. (10/24/16). "Press Release: Oasmia Enters into Collaboration Agreement for Novel Cancer Project". Uppsala. | ||
Record changed: 2019-07-13 |
Advertisement

More documents for Karo Pharma (Group)
- [1] Medivir AB. (12/15/16). "Press Release: Medivir Completes the Divestment of BioPhausia – a Transfer of approx. SEK 870m to the Shareholders through a Share Redemption Offer Will Be Proposed". Stockholm....
- [2] Medivir AB. (11/1/16). "Press Release: Medivir Divests Its Pharmaceutical Company BioPhausia (Nordic Brands) to Karo Pharma". Stockholm....
- [3] Oasmia Pharmaceutical AB. (10/24/16). "Press Release: Oasmia Enters into Collaboration Agreement for Novel Cancer Project". Uppsala....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top